U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SERIBANTUMAB
1N3L70MDFX
Investigational
General
Names
9
Classification
2
Identifiers
10
Subunits
4
Related Substances
1
SERIBANTUMAB
1N3L70MDFX
Investigational
General
Approval Year
Unknown
149,124
Names
9
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SERIBANTUMAB
Official Name
English
seribantumab [INN]
Preferred Name
English
SAR-256212
Code
English
Seribantumab [WHO-DD]
Common Name
English
MM121
Code
English
Showing 1 to 5 of 9 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Treatment of heregulin-positive non-small cell lung cancer
FDA ORPHAN DRUG
545516
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000172236
PRIMARY
USAN
BC-136
PRIMARY
CAS
1334296-12-6
PRIMARY
ChEMBL
CHEMBL3545071
PRIMARY
FDA UNII
1N3L70MDFX
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
1N3L70MDFX
SERIBANTUMAB